1. Targeting tryptophan availability to tumors: the answer to immune escape?
   Abdulla A‐B Badawy, 2018, Immunology & Cell Biology CrossRef
2. Autophagy-Inducing Inhalable Co-crystal Formulation of Niclosamide-Nicotinamide for Lung Cancer Therapy
   Eupa Ray et al, 2020, AAPS PharmSciTech CrossRef
3. Modulating the Radiation Response for Improved Outcomes in Breast Cancer
   Andrea M. Pesch et al, 2021, JCO Precision Oncology CrossRef
4. Spectroscopic, quantum computational, topological, Fukui functions and molecular docking analysis on a potential anti-cancer molecule Nicotinamide by DFT method
   K. Rajkumar et al, 2024, Journal of Molecular Structure CrossRef
5. Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective
   Mukul Arvind Gharote et al, 2021, International Journal of Molecular and Immuno Oncology CrossRef
6. Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cells
   Avital Granit Mizrahi et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
7. NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability
   Kamalakannan Palanichamy et al, 2017, Clinical Cancer Research CrossRef
8. Nicotinamide induces mitochondrial-mediated apoptosis through oxidative stress in human cervical cancer HeLa cells
   Yi Feng et al, 2017, Life Sciences CrossRef
9. Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy
   Alejandro Schcolnik-Cabrera et al, 2021, Scientific Reports CrossRef
10. Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer
    Hanxiao Cui et al, 2023, Frontiers in Immunology CrossRef
11. Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
    Benson Chellakkan Selvanesan et al, 2020, Journal for ImmunoTherapy of Cancer CrossRef
12. Poly(ADP-ribose) Glycohydrolase Inhibition Sequesters NAD+ to Potentiate the Metabolic Lethality of Alkylating Chemotherapy in IDH-Mutant Tumor Cells
    Hiroaki Nagashima et al, 2020, Cancer Discovery CrossRef
13. DNA Repair and Therapeutic Strategies in Cancer Stem Cells
    Matthew S. Gillespie et al, 2023, Cancers CrossRef
14. Current Trends in Sirtuin Activator and Inhibitor Development
    Karina L. Bursch et al, 2024, Molecules CrossRef
15. Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide
    Abdulla A.-B. Badawy, 2020, Bioscience Reports CrossRef
16. The Role of Nicotinamide in Cancer Chemoprevention and Therapy
    Ilias P. Nikas et al, 2020, Biomolecules CrossRef
17. Improved delivery of Mcl-1 and survivin siRNA combination in breast cancer cells with additive siRNA complexes
    Tinnabhop Santadkha et al, 2022, Investigational New Drugs CrossRef
18. High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective
    Mukul Arvind Gharote, 2024, International Journal of Molecular and Immuno Oncology CrossRef
19. Nicotinamide (niacin) supplement increases lipid metabolism and ROS‐induced energy disruption in triple‐negative breast cancer: potential for drug repositioning as an anti‐tumor agent
    Minsun Jung et al, 2022, Molecular Oncology CrossRef
20. The Role of Poly(ADP-Ribose) Polymerase-1 in Cutaneous Wound Healing
    Jaideep Banerjee et al, 2019, Advances in Wound Care CrossRef
21. Possible mechanisms of cancer prevention by nicotinamide
    Aitziber Buqué et al, 2021, British Journal of Pharmacology CrossRef
22. Endogenous metabolism in endothelial and immune cells generates most of the tissue vitamin B3 (nicotinamide)
    Julianna D. Zeidler et al, 2022, iScience CrossRef